Primaquine-induced hemolytic anemia: Formation of free radicals in rat erythrocytes exposed to 6-methoxy-8-hydroxylaminoquinoline

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 3, 2002, Pages 1121-1129

  Bolchoz, Laura J C ^a   Gelasco, Andrew K ^a,b   Jollow, David J ^a   McMillan, David C ^a,c  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHOXYCARBONYL 2 METHYL 3,4 DIHYDRO 2H PYRROLE 1 OXIDE; 6 METHOXY 8 HYDROXYLAMINOQUINOLINE; FERRYLHEMOGLOBIN; FREE RADICAL; GLUTATHIONE; HEMOGLOBIN DERIVATIVE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; OXYGEN; PRIMAQUINE; PYRROLE DERIVATIVE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD TOXICITY; CELL SUSPENSION; CONTROLLED STUDY; DRUG EXPOSURE; ELECTRON SPIN RESONANCE; ERYTHROCYTE; HEMOLYTIC ANEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY; SPIN TRAPPING;

ANEMIA, HEMOLYTIC; ANIMALS; ERYTHROCYTES; FREE RADICALS; MALE; PRIMAQUINE; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036896929     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.041459     Document Type: Article

References (39)

1. Agarwal S, Gupta UR, Daniel CS, Gupta RC, Anand N, and Agarwal SS (1991) Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to prima quine, primaquine enantiomers, and its two putative metabolites. II. Effect on red blood cell membrane, lipid peroxidation, MC-540 staining and scanning electron microscopic studies. Biochem Pharmacol 41:17-21.
2. Baird JK, McCormick GJ, and Canfield CJ (1986) Effects of nine synthetic putative metabolites of primaquine on activity of the hexose monophosphate shunt in intact human red blood cells in vitro. Biochem Pharmacol 35:1099-1106.
3. Berzofsky JA, Peisach J, and Blumberg WE (1971) Sulfheme proteins. I. Optical and magnetic properties of sulfmyoglobin and its derivatives. J Biol Chem 246:3367-3377.
4. Beutler E (1969) Drug-induced hemolytic anemia. Pharmacol Rev 21:73-103.
5. Beutler E (1971) Abnormalities of the hexose monophosphate shunt. Semin Hematol 8:311-347.
6. Bolchoz LJ, Budinsky RA, McMillan DC, and Jollow DJ (2001) Primaquine-induced hemolytic anemia: Formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. J Pharmacol Exp Ther 297:509-515.
7. Bolchoz LJ, Morrow JD, McMillan DC, and Jollow DJ (2002) Primaquine-induced hemolytic anemia: Effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins and morphology. J Pharmacol Exp Ther 303:141-148.
8. Bradshaw TP, McMillan DC, Crouch RK, and Jollow DJ (1995) Identification of free radicals produced in rat erythrocytes exposed to hemolytic concentrations of phenylhydroxylamine. Free Rad Biol Med 18:279-285.
9. Bradshaw TP, McMillan DC, Crouch RK, and Jollow DJ (1997) Formation of free radicals and protein mixed disulfides in rat red cells exposed to dapsone hydroxylamine. Free Rad Biol Med 22:1183-1193.
10. Ciccoli L, Ferrali M, Rossi V, Signorini C, Alessandrini C, and Comporti M (1999) Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver. Toxicol Lett 110:57-66.
11. Ciccoli L, Signorini C, Alessandrini C, Ferrali M, and Comporti M (1994) Iron release, lipid peroxidation and morphological alterations of erythrocytes exposed to acrolein and phenylhydrazine. Exp Mol Pathol 60:108-118.
12. Cohen G and Hochstein P (1963) Glutathione peroxidase: The primary agent for the elimination of hydrogen peroxide in erythrocytes. Biochemistry 6:1420-1428.
13. Dong MG, Thomas PD, and Pozanansky MJ (1994) Oxidation of spin trap 5,5-dimethyl-1-pyrroline-1-oxide in an electron paramagnetic resonance study of the reaction of methemoglobin with hydrogen peroxide. Free Rad Biol Med 16:493-500.
14. Eaton JW (1991) Catalases and peroxidases and glutathione and hydrogen peroxide: Mysteries of the bestiary. J Lab Clin Med 118:3-4.
15. Ferrali M, Signorini C, Ciccoli L, and Comporti M (1992) Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem J 285:295-301.
16. Fletcher KA, Barton PF, and Kelly JA (1988) Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine. Biochem Pharmacol 37:2683-2690.
17. Fridovich I (1986) Biological effects of the superoxide radical. Arch Biochem Biophys 247:1-11.
18. Galaris D, Sevanian A, Cadenas E, and Hochstein P (1990) Ferrylmyoglobin-catalyzed linoleic acid peroxidation. Arch Biochem Biophys 281:163-169.
19. Giulivi C and Davies KJA (1990) A novel antioxidant role for hemoglobin. J Biol Chem 265:19453-19460.
20. Grossman SJ and Jollow DJ (1988) Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. J Pharmacol Exp Ther 244:118-125.
21. Gutteridge JM (1986) Iron promoters of the Fenton reaction and lipid peroxidation an be released from hemoglobin by peroxides. FEBS Lett 201:291-295.
22. Hanna PM, Chamulitrat W, and Mason RP (1992) When are metal ion dependent hydroxyl and alkoxyl radical adducts of 5,5-dimethyl-1-pyrroline-N-oxide artifacts? Arch Biochem Biophys 296:640- 644.
23. Harel S and Kanner J (1988) The generation of ferryl or hydroxyl radicals during interaction of haemproteins with hydrogen peroxide. Free Radical Res Commun 5:21-34.
24. Harrison JH Jr and Jollow DJ (1986) Role of aniline metabolites in aniline-induced hemolytic anemia. J Pharmacol Exp Ther 238:1045-1054.
25. Harrison J Jr and Jollow DJ (1987) Contribution of aniline metabolites to aniline-induced methemoglobinemia. Mol Pharmacol 32:423-431.
26. Jensen CB and Jollow DJ (1991) The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia. Toxicol Appl Pharmacol 111:1-12.
27. Kanner J and Harel S (1985a) Initiation of membrane lipid peroxidation by activated metmyoglobin and methemoglobin. Arch Biochem Biophys 237:314-321.
28. 2 activated metmyoglobin. Lipids 20:625-628.
29. Kiese M (1974) Methemoglobinemia: A Comprehensive Treatise, CRC Press, Cleveland, OH.
30. Makino K, Hagiwara T, Hagi A, Nishi M, and Murakami A (1990) Cautionary note for DMPO spin trapping in the presence of iron ion. Biochem Biophys Res Commun 172:1073-1080.
31. Maples KR, Eyer P, and Mason RP (1990) Aniline-, phenylhydroxylamine-, nitroso-benzene- and nitrobenzene-induced hemoglobin thiyl free radical formation in vivo and in vitro. Mol Pharmacol 37:311-318.
32. Munday R and Winterbourn CC (1989) Reduced glutathione in combination with superoxide dismutase as a important biological antioxidant defense mechanism. Biochem Pharmacol 38:4349-4352.
33. Olive G, Mercier A, Le Moigne F, Rockenbaur A, and Tordo P (2000) 2-Ethoxycar-bonyl-2-methyl-3,4-dihydro-2H-pyrrole-1-oxide: Evaluation of the spin trapping properties. Free Rad Biol Med 28:403-408.
34. Puppo A and Halliwell B (1988) Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is hemoglobin a biological Fenton reagent? Biochem J 249:185-190.
35. Rostorfer HH and Cormier MJ (1957) The formation of "hydrogen peroxide" in the reaction of oxyhemoglobin with methemoglobin forming agents. Arch Biochem Biophys 71:235-249.
36. Strother A, Allahyari R, Buchholz J, Fraser IM, and Tilton BE (1984) In vitro metabolism of the antimalarial agent primaquine by mouse liver enzymes and identification of a methemoglobin-forming metabolite. Drug Metab Dispos 12:35-44.
37. Thornalley PJ (1986) Theory and biological applications of the electron spin resonance technique of spin trapping. Life Chem Rep 4:57-112.
38. Winterbourn CC (1993) Superoxide as an intracellular radical sink. Free Rad Biol Med 14:85-90.
39. Zhang H, Joseph J, Vasquez-Vivar J, Karoui H, Nsanzumuhire C, Martasek P, Tordo P, and Kalyanaraman B (2000) Detection of superoxide anion using an isotopically labeled nitrone spin trap: Potential biological applications. FEBS Lett 473:58-62.